Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles

International Journal of Pharmaceutics

Volumn 489, Issue 1-2, 2015, Pages 311-317

  Danesh, Noor Mohammad ^a,b   Lavaee, Parirokh ^c,d   Ramezani, Mohammad ^a   Abnous, Khalil ^e   Taghdisi, Seyed Mohammad ^f  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Research Institute of Food Science and Technology (RIFST)   (Iran)

^c FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Keywords Aptamer Targeted delivery Daunorubicin Leukemia Gold nanoparticles

Indexed keywords

APTAMER; DAUNORUBICIN; GOLD NANOPARTICLE; ANTINEOPLASTIC ANTIBIOTIC; DELAYED RELEASE FORMULATION; GOLD; METAL NANOPARTICLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; FLUOROMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; MTT ASSAY; MYELOMA CELL; PH; PRIORITY JOURNAL; ADMINISTRATION AND DOSAGE; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; CELL SURVIVAL; DAUNORUBICIN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; METAL NANOPARTICLES; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84929191128     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.072     Document Type: Article

References (42)

1. V. Bagalkot, O.C. Farokhzad, R. Langer, and S. Jon An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform Angew. Chem. - Int. Ed. 45 2006 8149 8152
2. Y. Bai, F. Feng, L. Zhao, C. Wang, H. Wang, M. Tian, J. Qin, Y. Duan, and X. He Aptamer/thrombin/aptamer-AuNPs sandwich enhanced surface plasmon resonance sensor for the detection of subnanomolar thrombin Biosens. Bioelectron. 47 2013 265 270
3. D. Bhojwani, J.J. Yang, and C.H. Pui Biology of childhood acute lymphoblastic leukemia Pediatr. Clin. North Am. 62 2015 47 60
4. C.C. Chang, S.C. Wei, T.H. Wu, C.H. Lee, and C.W. Lin Aptamer-based colorimetric detection of platelet-derived growth factor using unmodified gold nanoparticles Biosens. Bioelectron. 42 2013 119 123
5. C.H. Chung, J.H. Kim, J. Jung, and B.H. Chung Nuclease-resistant DNA aptamer on gold nanoparticles for the simultaneous detection of Pb2+ and Hg2+ in human serum Biosens. Bioelectron. 41 2013 827 832
6. J. Conde, M. Larguinho, A. Cordeiro, L.R. Raposo, P.M. Costa, S. Santos, M.S. Diniz, A.R. Fernandes, and P.V. Baptista Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis Nanotoxicology 8 2014 521 532
7. S.L. Cooper, and P.A. Brown Treatment of pediatric acute lymphoblastic leukemia Pediatr. Clinics North Am. 62 2015 61 73
8. D.M. Eckmann, R.J. Composto, A. Tsourkas, and V.R. Muzykantov Nanogel carrier design for targeted drug delivery J. Mater. Chem. B 2 2014 8085 8097
9. K.R. Fox, R. Webster, R.J. Phelps, I. Fokt, and W. Priebe Sequence selective binding of bis-daunorubicin WP631 to DNA Eur. J. Biochem. 271 2004 3556 3566
10. I. Fratoddi, I. Venditti, C. Cametti, and M.V. Russo Gold nanoparticles and gold nanoparticle-conjugates for delivery of therapeutic molecules. Progress and challenges J. Mater. Chem. B 2 2014 4204 4220
11. L. Gallois, M. Fiallo, A. Laigle, W. Priebe, and A. Garnier-Suillerot The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids Eur. J. Biochem. 241 1996 879 887
12. S.C.B. Gopinath, T. Lakshmipriya, and K. Awazu Colorimetric detection of controlled assembly and disassembly of aptamers on unmodified gold nanoparticles Biosens. Bioelectron. 51 2014 115 123
13. H. Hou, A. Nieto, F. Ma, W.R. Freeman, M.J. Sailor, and L. Cheng Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon J. Control. Release 178 2014 46 54
14. Y.F. Huang, D. Shangguan, H. Liu, J.A. Phillips, X. Zhang, Y. Chen, and W. Tan Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells ChemBioChem 10 2009 862 868
15. K.J. Huang, Y.J. Liu, G.W. Shi, X.R. Yang, and Y.M. Liu Label-free aptamer sensor for 17β-estradiol based on vanadium disulfide nanoflowers and Au nanoparticles Sens. Actuators B: Chem. 201 2014 579 585
16. G. Jiang, M. Zhang, B. Yue, M. Yang, C. Carter, S.Z. Al-Quran, B. Li, and Y. Li PTK7: A new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia Leukemia Res. 36 2012 1347 1353
17. G.J.L. Kaspers, M. Zimmermann, D. Reinhardt, B.E.S. Gibson, R.Y.J. Tamminga, O. Aleinikova, H. Armendariz, M. Dworzak, S.Y. Ha, H. Hasle, L. Hovi, A. Maschan, Y. Bertrand, G.G. Leverger, B.I. Razzouk, C. Rizzari, P. Smisek, O. Smith, B. Stark, and U. Creutzig Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the international BFM study group J. Clin. Oncol. 31 2013 599 607
18. J.M. Kwan, A.M. Fialho, M. Kundu, J. Thomas, C.S. Hong, T.K. Das Gupta, and A.M. Chakrabarty Bacterial proteins as potential drugs in the treatment of leukemia Leukemia Res. 33 2009 1392 1399
19. X. Li, L. Wang, Y. Fan, Q. Feng, and F.Z. Cui Biocompatibility and toxicity of nanoparticles and nanotubes J. Nanomater. 2012
20. L. Li, D. Xiang, S. Shigdar, W. Yang, Q. Li, J. Lin, K. Liu, and W. Duan Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells Int. J. Nanomed. 9 2014 1083 1096
21. N. Li, Q. Zhao, C. Shu, X. Ma, R. Li, H. Shen, and W. Zhong Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug delivery Int. J. Pharm. 478 2015 644 654
22. Y. Lian, F. He, H. Wang, and F. Tong A new aptamer/graphene interdigitated gold electrode piezoelectric sensor for rapid and specific detection of Staphylococcus aureus Biosens. Bioelectron. 65 2015 314 319
23. J. Liu, Z. Guan, Z. Lv, X. Jiang, S. Yang, and A. Chen Improving sensitivity of gold nanoparticle based fluorescence quenching and colorimetric aptasensor by using water resuspended gold nanoparticle Biosens. Bioelectron. 52 2014 265 270
24. P. Luo, Y. Liu, Y. Xia, H. Xu, and G. Xie Aptamer biosensor for sensitive detection of toxin A of Clostridium difficile using gold nanoparticles synthesized by Bacillus stearothermophilus Biosens. Bioelectron. 54 2014 217 221
25. C. Matos, C. Moutinho, and P. Lobão Liposomes as a model for the biological membrane: studies on daunorubicin bilayer interaction J. Membr. Biol. 245 2012 69 75
26. V. Raffa, G. Ciofani, O. Vittorio, C. Riggio, and A. Cuschieri Physicochemical properties affecting cellular uptake of carbon nanotubes Nanomedicine 5 2010 89 97
27. R. Senthilkumar, D.S. Karaman, P. Paul, E.M. Björk, M. Odén, J.E. Eriksson, and J.M. Rosenholm Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect Biomater. Sci. 3 2015 103 111
28. W. Shan, Y. Pan, H. Fang, M. Guo, Z. Nie, Y. Huang, and S. Yao An aptamer-based quartz crystal microbalance biosensor for sensitive and selective detection of leukemia cells using silver-enhanced gold nanoparticle label Talanta 126 2014 130 135
29. Y. Shi, H. Dai, Y. Sun, J. Hu, P. Ni, and Z. Li Fluorescent sensing of cocaine based on a structure switching aptamer, gold nanoparticles and graphene oxide Analyst 138 2013 7152 7156
30. F. Shi, X. Yang, Y. Gong, R. Shi, D. Naren, and J. Wu The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia Anti-Cancer Drugs 2014
31. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R.R. Bhonde, and M. Sastry Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview Langmuir 21 2005 10644 10654
32. G. Soni, and K.S. Yadav Applications of nanoparticles in treatment and diagnosis of leukemia Mater. Sci. Eng. C 47 2015 156 164
33. J.J. Storhoff, R. Elghanian, R.C. Mucic, C.A. Mirkin, and R.L. Letsinger One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes J. Am. Chem. Soc. 120 1998 1959 1964
34. J. Sun, A. Guo, Z. Zhang, L. Guo, and J. Xie A conjugated aptamer-gold nanoparticle fluorescent probe for highly sensitive detection of rHuEPO-α Sensors 11 2011 10490 10501
35. S.M. Taghdisi, K. Abnous, F. Mosaffa, and J. Behravan Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer J. Drug Targeting 18 2010 277 281
36. S.M. Taghdisi, P. Lavaee, M. Ramezani, and K. Abnous Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 77 2011 200 206
37. P. Thompson, H.E. Wheeler, S.M. Delaney, R. Lorier, U. Broeckel, M. Devidas, G.H. Reaman, K. Scorsone, L. Sung, M.E. Dolan, and S.L. Berg Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group Cancer Chemother. Pharmacol 74 2014 831 838
38. J.K. Vasir, and V. Labhasetwar Targeted drug delivery in cancer therapy Technol. Cancer Res. Treat. 4 2005 363 374
39. H. Yang, L. Du, X. Tian, Z. Fan, C. Sun, Y. Liu, J.A. Keelan, and G. Nie Effects of nanoparticle size and gestational age on maternal biodistribution and toxicity of gold nanoparticles in pregnant mice Toxicol. Lett. 230 2014 10 18
40. K. Yehl, J.P. Joshi, B.L. Greene, R.B. Dyer, R. Nahta, and K. Salaita Catalytic deoxyribozyme-modified nanoparticles for RNAi-independent gene regulation ACS Nano 6 2012 9150 9157
41. T.N. Zamay, O.S. Kolovskaya, Y.E. Glazyrin, G.S. Zamay, S.A. Kuznetsova, E.A. Spivak, M. Wehbe, A.G. Savitskaya, O.A. Zubkova, A. Kadkina, X. Wang, D. Muharemagic, A. Dubynina, Y. Sheina, A.B. Salmina, M.V. Berezovski, and A.S. Zamay DNA-aptamer targeting vimentin for tumor therapy in vivo Nucleic Acid Ther. 24 2014 160 170
42. F. Zhao, Q. Xie, M. Xu, S. Wang, J. Zhou, and F. Liu RNA aptamer based electrochemical biosensor for sensitive and selective detection of cAMP Biosens. Bioelectron. 66 2015 238 243